510(k) Report

510(k) · Cleared

Cleared

ALGO Pro Newborn Hearing Screener (ALGO Pro)

K233649510(k) TraditionalCleared Mar 8, 2024115-day reviewClass II21 CFR 882.1900

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · GWJ Stimulator, Auditory, Evoked Response

Cleared on Mar 8, 2024 as substantially equivalent to K073665 (Natus Medical, Inc., 2008) after a 115-day review. Its family tree reaches back 3 generations to 1995.

Decided
Mar 8, 2024
Review
115 days
Class
Class II
Product code
GWJ
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K936039 (1995). No later device cites it as a predicate yet.

  1. Root · 3 generations backK936039 Algo-2 Newborn Hearing ScreenerNatus Medical, Inc. · 1995 · Recalled
  2. 2 generations backK013137 Algo 3 Newborn Hearing ScreenerNatus Medical, Inc. · 2001 · Recalled
  3. 1 generation backK073665 Algo 5 Newborn Hearing ScreenerNatus Medical, Inc. · 2008
  4. This deviceK233649 ALGO Pro Newborn Hearing Screener (ALGO Pro)Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K936039Algo-2 Newborn Hearing ScreenerNatus Medical, Inc.19951
−2K013137Algo 3 Newborn Hearing ScreenerNatus Medical, Inc.20011
−1K073665Algo 5 Newborn Hearing ScreenerNatus Medical, Inc.2008—
0 (this device)K233649ALGO Pro Newborn Hearing Screener (ALGO Pro)Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek)2024—
FIG. 1 — Lineage of K233649, 1995–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWJ device

  1. #1 K242954 Integrity V500 (Integrity, Integrity with VEMP)score 10.0 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K073665Algo 5 Newborn Hearing Screener
Summary page 4
…Regulation Number: 21 CFR 882.1900 Classification Name: Stimulator, Auditory, Evoked Response Product code: GWJ Device Class: II Predicate Device: ALGO 5 510(k) number: K073665 Page 1 of 11 ALGO Pro 510k DEVICE DESCRIPTION:…
Natus Medical, Inc.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 2 companies; a new generation was cleared every 6.8 years on median.
  • 2 of the 3 ancestors have a recall of any class.

How does its category compare?

All GWJ devices

GWJ Stimulator, Auditory, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · GWJ

2in 2024

2007: 22008: 42009: 42010: 12011: 22012: 12013: 22014: 22015: 12017: 22020: 12021: 12022: 12024: 2
2007high 4 (2008) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWJ

111in 2009

2008: 64 days median2009: 111 days median
2007high 111 (2009) · low 64 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWJ

1in 2025

2008: 12010: 12019: 12025: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWJ

1in 2025

2010: 22011: 52012: 12013: 12015: 32016: 12017: 432018: 242019: 52020: 32021: 32022: 82023: 62024: 72025: 1
2007high 43 (2017) · low 0 (2007)2025

MAUDE reports naming product code GWJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200846410
2009411100
20101—12
20112—05
20121—01
20132—01
20142—00
20151—03
20160—01
20172—043
20180—024
20190—15
20201—03
20211—03
20221—08
20230—06
20242—07
20250—11
20260—0—

What is it indicated for?

The ALGO Pro Newborn Hearing Screener is a mobile, noninvasive instrument used to screen infants for hearing loss. The screener uses Automated Auditory Brainstem Response (AABR®) technology for automated analysis of Auditory Brainstem Response (ABR) signals recorded from the patient. The screener is intended for babies between the ages of 34 weeks (gestation age) and 6 months. Babies should be well enough to be ready for discharge from the hospital, and…

Read the full statement (157 words)

The ALGO Pro Newborn Hearing Screener is a mobile, noninvasive instrument used to screen infants for hearing loss. The screener uses Automated Auditory Brainstem Response (AABR®) technology for automated analysis of Auditory Brainstem Response (ABR) signals recorded from the patient. The screener is intended for babies between the ages of 34 weeks (gestation age) and 6 months. Babies should be well enough to be ready for discharge from the hospital, and should be asleep or in a quiet state at the time of screening. The screener is simple to operate. It does not require special technical skills or interpretation of results. Basic training with the equipment is sufficient to learn how to screen infants who are in good health and about to be discharged from the hospital. A typical screening process can be completed in 15 minutes or less. Sites appropriate for screening include the well-baby nursery, NICU, mother’s bedside, audiology suite, outpatient clinic, or doctor's office.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233649: ALGO Pro Newborn Hearing Screener (ALGO Pro).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K233649

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026